
Academic Journal
Q3Future Microbiology
About Future Microbiology
Future Microbiology is a scholarly journal published by Taylor and Francis Ltd.. SCImago 2025 lists it in Q3, with an SJR of 0.54 and H-index of 111.
Coverage: 2006-2026. Research categories: Microbiology (Q3); Microbiology (medical) (Q3).
Source-backed journal facts
Topics in published research
Antibiotic Resistance in Bacteria; Antifungal resistance and susceptibility; Bacterial biofilms and quorum sensing; Fungal Infections and Studies; Antimicrobial Resistance in Staphylococcus; Tuberculosis Research and Epidemiology.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Antifungal activity of Anacardium occidentale against clinical strains of Sporothrix brasiliensis
Giselle da Silva Barbosa, Bruna Rodrigues de Sousa, Layanne de Oliveira Ferro, Magda Rhayanny Assunção Ferreira et al.
2026-10-04 · DOI: 10.1080/17460913.2026.2740992An attempt to identify the anti-biofilm aptitude of Barleria lupulina Lindl. Leaf extract on clinical isolates of multidrug-resistant Staphylococcus aureus
Saroj Ballav, Debarati Jana, Tuhin Manna, Nabajyoti Baildya et al.
2026-09-16 · DOI: 10.1080/17460913.2026.2732389Enhanced antibacterial and antibiofilm activity of Artemisia aucheri Boiss. extract-loaded niosomes against clinical MRSA isolates
Fatemeh Ashrafi, Mahtab Majdabadi, Pooria Moulavi, Sepideh Asadi et al.
2026-09-15 · DOI: 10.1080/17460913.2026.2730081Practical use of piperacillin MICs to distinguish β-lactamase-producing isolates from non-producing isolates in Haemophilus influenzae
Keisuke Nishikawa, Shuji Mori, Kenichiro Ohnuma, Masanori Kameoka et al.
2026-09-10 · DOI: 10.1080/17460913.2026.2728879Correction
2026-09-08 · DOI: 10.1080/17460913.2026.2730734Predictive value of urinalysis parameters for risk stratification of Staphylococcus aureus bacteremia in patients with Staphylococcus aureus bacteriuria
Fatih Çubuk, Özlem Aldemir, Murtaza Öz
2026-09-04 · DOI: 10.1080/17460913.2026.2728898Tumor-linked microbiota in the breast: a systematic review and meta-analysis
Assia Dardouri, Marouane Chahbouni, Meryem Meftah Elkhair, Said Lazar et al.
2026-08-13 · DOI: 10.1080/17460913.2026.2728819Establishment and characterization of a mouse model with chronic pneumonia infected by Pseudomonas aeruginosa
Lingli Ai, Lu Li, Lingfei Hu, Jin Zhao et al.
2026-08-13 · DOI: 10.1080/17460913.2026.2726070In vitro activity of beta-lactam/beta-lactamase inhibitors, colistin, tigecycline, and eravacycline against carbapenemase-producing uropathogenic Enterobacterales
Shaista Bakhat, Fakhur Uddin, Naresh Kumar, Mohammed Alorabi et al.
2026-08-13 · DOI: 10.1080/17460913.2026.2726703Digital twin of the gut microbiome: toward predictive health modelling
Ruqaiyyah Siddiqui, Naveed Ahmed Khan
2026-08-13 · DOI: 10.1080/17460913.2026.2722871Mycobacterial vaccination of fish and human tuberculin skin test reactivity: a testable One Health interface
Antonia Mataragka
2026-08-13 · DOI: 10.1080/17460913.2026.2727274Evaluation of a rapid multispectral autofluorescence device for detection and classification of bacterial infections in wounds reported to a tertiary hospital in Delhi
Anubhav Mondal, Aninda Debnath, Jugal Kishore, Sneha Ranjan et al.
2026-08-13 · DOI: 10.1080/17460913.2026.2728834A systematic review evaluating efficacy of probiotics in prevention and treatment of bacterial infections
Tanya Bhagat, Anjana Goyal, Tanushri Chatterji
2026-07-24 · DOI: 10.1080/17460913.2026.2715938Targeting PPARγ–NF-κB: (+)-catechin reverses Clostridioides difficile toxin A-induced intestinal barrier dysfunction
Shufeng Li, Yibo Luan, Zongmin Li, Yuting Lu et al.
2026-07-24 · DOI: 10.1080/17460913.2026.2719149Unraveling the bidirectional interplay of the gut microbiota with chemotherapy and radiotherapy in colorectal cancer: from pathogenesis to probiotic interventions
Ke Huang, Gengfan Liang, Lanfang Jiang, Quanzhi Qing et al.
2026-07-24 · DOI: 10.1080/17460913.2026.2720339Capnocytophaga canimorsus spondylodiscitis: an unusual presentation of a zoonotic infection
Raffaella Tiziana Benedetto, Pierluigi Del Vecchio, Rosalia Graffeo, Melinda Mariotti et al.
2026-07-24 · DOI: 10.1080/17460913.2026.2718652Genomic characterization of virulence and disinfectant resistant determinants in multidrug-resistant Escherichia coli and Klebsiella pneumoniae from urban wastewater treatment plants in Windhoek, Namibia
Smthokozele Sikabongo, Graça K. Kandanda, Uvatera Maurihungirire, Charlize L. Rix et al.
2026-07-24 · DOI: 10.1080/17460913.2026.2719190Virulence factors of Cryptococcus neoformans and Cryptococcus gattii : two sides of the same coin
Daniel Felipe Freitas de Jesus, Larissa Dunkl Brujas, Thayná Lopes Barreto, Letícia Serafim da Costa et al.
2026-07-24 · DOI: 10.1080/17460913.2026.2722813Revisiting Staphylococcus aureus decolonization: balancing efficacy, antimicrobial resistance, and precision infection prevention
Hadeel Mohammed Abbood, Karolin Hijazi
2026-07-24 · DOI: 10.1080/17460913.2026.2715914Synergy and mechanism of tedizolid in combination with fluconazole against resistant Candida albicans
Rui Feng, Shuang Wang, Jiyong Wu, Ting Wang et al.
2026-07-24 · DOI: 10.1080/17460913.2026.2721915Reviews
Community Reviews
Version History
October 4, 2026 at 9:16 pm
October 2, 2026